Two female scientists tend green plants in a GreenLight greenhouse
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
30. Mai 2023 07:01 ET | GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
A wide shot of a greenhouse at GreenLight's RTP facility
GreenLight Biosciences Releases Inaugural Sustainability Report
12. April 2023 06:59 ET | GreenLight Biosciences
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s...
a close up of a computer screenshowing plant health data
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
30. März 2023 16:05 ET | GreenLight Biosciences
BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to...
a vista of Kigali city from the Northern side
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
01. Februar 2023 07:20 ET | GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
Dr. Akinwande
Midwest Institute for Non-Surgical Therapy (MINT) Introduces New Therapy to Treat Men With Enlarged Prostates
21. Oktober 2022 09:00 ET | The Midwest Institute for Nonsurgical Therapy
ST. LOUIS, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Midwest Institute for Non-surgical Therapy (MINT) has introduced a new therapy to treat men with benign prostatic hyperplasia (BPH). The condition, which...
greenlight logo png.png
GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award
10. Mai 2022 13:04 ET | GreenLight Biosciences
BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- An RNA-based solution by GreenLight Biosciences designed to protect honeybees from the Varroa destructor mite was named a finalist by Fast Company for its...